Montage Technology Group Ltd (NASDAQ:MONT) a global fabless provider of analog and mixed-signal semiconductor solutions addressing the home entertainment and cloud computing markets, announced that on May 20, 2014, Montage Technology Group Limited (the “Company”) received a letter (the “Letter”) from the NASDAQ Stock Market LLC (“NASDAQ”) indicating that NASDAQ has determined that the Company’s failure to file its Form 10-Q for the period ended March 31, 2014 with the Securities and Exchange Commission serves as an additional basis to delist the ordinary shares of the Company pursuant to NASDAQ Listing Rule 5250(c)(1). Montage Technology Group Ltd (NASDAQ:MONT) net profit margin is 15.70% and weekly performance is -11.59%. On last trading day company shares ended up $17.17. Analysts mean target price for the company is $25.70. Montage Technology Group Ltd (NASDAQ:MONT) distance from 50-day simple moving average (SMA50) is -14.77%.
Kirkland’s Inc. (NASDAQ:KIRK)’s first-quarter 2014 earnings of 12 cents per share surpassed both the year-ago results as well as the Zacks Consensus Estimate of 10 cents by 20.0%, backed by higher sales and comps which offset the highly promotional environment in the industry. Earnings were at the higher end of management’s guidance range of 10 to 12 cents. Net sales went up 6.9% to $108.3 million compared with $101.2 million in the first quarter of fiscal 2014. Sales exceeded management’s expected range of $105–$106 million due to higher-than-expected comps. Kirkland’s, Inc. (NASDAQ:KIRK) shares fell -6.28% in last trading session and ended the day on $17.92. Gross Margin is 39.30% and its return on assets is 6.60%. Kirkland’s, Inc. (NASDAQ:KIRK) quarterly performance is 1.59%.
On May 16, Vermillion Inc. (NASDAQ:VRML) on Thursday posted a loss of $4.2 million in the first quarter, or 11 cents per share, on revenue of $305,000, compared to a loss of $2.6 million, or 17 cents per share, on revenue of $328,000 in the year-earlier period. That revenue was derived from Vermillion’s partnership with Quest Diagnostics, which has been the sole marketing channel for the company’s OVA1 test for ovarian cancer. The company is ending its current partnership with Quest, though it will likely continue to do business with the diagnostics giant, and is developing new sales channels including the recently opened Aspira Labs facility. Vermillion, Inc. (NASDAQ:VRML) shares moved down -11.60% in last trading session and was closed at $2.59, while trading in range of $2.57 – $2.91. Vermillion, Inc. (NASDAQ:VRML) year to date (YTD) performance is 9.75%.
OXiGENE, Inc. (NASDAQ:OXGN) a biopharmaceutical company developing novel cancer therapeutics, announced that it has entered into definitive agreements with institutional investors to purchase an aggregate of $16 million of registered shares of OXiGENE common stock in an at-the-market direct offering at $ 2.9625 per share. For each share of common stock purchased, investors will receive one-half of an unregistered warrant to purchase a share of common stock at an exercise price of $2.90 per share, which are exercisable immediately and expire five years and three months from the date of issuance. OXiGENE Inc (NASDAQ:OXGN) ended the last trading day at $2.71. Company weekly volatility is calculated as 6.23% and price to cash ratio as 5.93. OXiGENE Inc (NASDAQ:OXGN) showed a negative weekly performance of -11.73%.
Independent oil and Natural Gas Company Royale Energy, Inc. (NASDAQ:ROYL) is surging in the market by a high of 35.23% after the company announced it had identified a large drillable target on Alaskan 3D Seismic. Royale Energy has confirmed the target to be 20,000 acres in size, strongly supported by Dry Hydrocarbon Indicators. The company expects prospective resource assessment to be made available to shareholders and stockholders soon. Royale Energy, Inc. (NASDAQ:ROYL) net profit margin is 9.51% and weekly performance is 10.68 %. On last trading day company shares ended up $3.11. Analysts mean target price for the company is $14.91. Royale Energy, Inc. (NASDAQ:ROYL) distance from 50-day simple moving average (SMA50) is 7.90%.